Kempe Allison, Patel Manish M, Daley Matthew F, Crane Lori A, Beaty Brenda, Stokley Shannon, Barrow Jennifer, Babbel Christine, Dickinson L Miriam, Tempte Jonathan L, Parashar Umesh D
Department of aPediatrics, School of Medicine, Colorado School of Public Health,University of Colorado Denver, Aurora, Colorado 80045, USA.
Pediatrics. 2009 Nov;124(5):e809-16. doi: 10.1542/peds.2008-3832. Epub 2009 Oct 12.
The goals were to assess, among pediatricians and family medicine physicians, (1) rates of offering the vaccine in their office; (2) knowledge of Advisory Committee on Immunization Practices recommendations; (3) barriers to use; and (4) factors associated with offering the vaccine.
Surveys of pediatricians and family medicine physicians were conducted in August to October 2007.
Response rates were 84% for pediatricians and 79% for family medicine physicians (N = 623). Proportions routinely offering the vaccine were 85% of pediatricians and 45% of family medicine physicians (P < .0001); 70% of pediatricians and 22% of family medicine strongly recommended the vaccine (P < .0001). Sixty-two percent of pediatricians and 32% of family medicine physicians (P < .0001) knew the age by which all 3 doses should be completed. Definite barriers to vaccine use included reported lack of coverage by insurance companies (family medicine physicians: 22%; pediatricians: 19%; not significant), costs of purchasing vaccine (family medicine physicians: 22%; pediatricians: 17%; not significant), lack of adequate reimbursement (family medicine physicians: 18%; pediatricians: 15%; not significant), concerns about safety (family medicine physicians: 25%; pediatricians: 9%; P < .0001), and concerns about adding another vaccine to the schedule (family medicine physicians: 22%; pediatricians: 5%; P < .0001).
Rates of offering the new rotavirus vaccine are high among pediatricians but <50% among family medicine physicians. Both specialties identified financial barriers to use of the vaccine, but family medicine physicians had significantly more concerns about safety and about adding another vaccine to the vaccination schedule.
目标是在儿科医生和家庭医学医生中评估：（1）在其诊所提供该疫苗的比例；（2）对免疫实践咨询委员会建议的了解情况；（3）使用障碍；以及（4）与提供该疫苗相关的因素。
在2007年8月至10月对儿科医生和家庭医学医生进行了调查。
儿科医生的回复率为84%，家庭医学医生的回复率为79%（N = 623）。常规提供该疫苗的比例，儿科医生为85%，家庭医学医生为45%（P <.0001）；70%的儿科医生和22%的家庭医学医生强烈推荐该疫苗（P <.0001）。62%的儿科医生和32%的家庭医学医生（P <.0001）知道所有三剂疫苗应完成接种的年龄。疫苗使用的明确障碍包括保险公司报告的覆盖不足（家庭医学医生：22%；儿科医生：19%；无显著差异）、购买疫苗的成本（家庭医学医生：22%；儿科医生：17%；无显著差异）、报销不足（家庭医学医生：18%；儿科医生：15%；无显著差异）、对安全性的担忧（家庭医学医生：25%；儿科医生：9%；P <.0001）以及对在疫苗接种计划中增加另一种疫苗的担忧（家庭医学医生：22%；儿科医生：5%；P <.0001）。
儿科医生中提供新型轮状病毒疫苗的比例较高，但家庭医学医生中该比例低于50%。两个专业都确定了疫苗使用的财务障碍，但家庭医学医生对安全性以及在疫苗接种计划中增加另一种疫苗的担忧明显更多。
